Russia has reached an agreement in principle to conduct clinical trials of its controversial coronavirus vaccine in Saudi Arabia, according to the head of its sovereign wealth fund.
Vast wealth and the promise of dramatic change make for cautious optimism concerning Saudi Arabia, the chief executive…0 Views | the publication reaches you by | Saudi Arabia Today
The Russians are working with a pharmaceutical company in the kingdom and have shared data from Phase I and Phase II trials with Saudi partners, the chief executive officer of the Russian Direct Investment Fund, Kirill Dmitriev, told Arab News. The company wasn’t identified.
“We’ll really engage with Saudi scientists and the Saudi Health Ministry,” Dmitriev said. “We believe that Saudi will be a very strong partner for our joint work on the Sputnik V vaccine.”
Earlier this month Russia approved a coronavirus shot before crucial tests have shown it’s safe and effective. The plan is to begin mass inoculation soon. A local association of multinational pharmaceutical companies has called the rushed regulatory approval risky.
The project for the design, engineering and procurement of the new 400,000m3/day Jubail II seawater reverse osmosis (SWRO)…0 Views | the publication reaches you by | Saudi Arabia Today
Do you have information you want to reach our readers?